Skip to main content

Peer Review reports

From: A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer’s disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial

Original Submission
27 Dec 2023 Submitted Original manuscript
18 Feb 2024 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
21 Feb 2024 Editorially accepted
4 Mar 2024 Article published 10.1186/s13063-024-08001-3

You can find further information about peer review here.

Back to article page